#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cystic fibrosis gastrointestinal disease Henoch-Schonlein purpura Chorioretinitis Squamous cell carcinoma of the oral cavity Cervix carcinoma Autoimmune myositis Epidermolysis bullosa Short stature Endometrial adenocarcinoma Pulmonary arterial hypertension Pleural mesothelioma malignant Pseudoxanthoma elasticum Ornithine transcarbamoylase deficiency Thrombotic thrombocytopenic purpura Congenital myopathy More trials…

    Learn about Rare Diseases

    Nephroblastoma – Basic Information Breast angiosarcoma Stevens-Johnson syndrome Angiosarcoma – Treatment Arterial tortuosity syndrome – Basic Information Alternating hemiplegia of childhood – Basic Information Hypereosinophilic syndrome – Treatment Cystic fibrosis – Trials in Disease Soft tissue sarcoma – Life with Disease Breast angiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clic-1901 Cart Dextrose Bp Opevesostat Tosilate Pitolisant Certolizumab Pegol Voclosporin Dexketoprofen 20-HYDROXYECDYSONE Cipaglucosidase Alfa Prasugrel Tenofovir Alafenamide TRAZODONE HYDROCHLORIDE Imipenem Anhydrate AGALSIDASE BETA Phenazone DISODIUM PHOSPHATE 68Ga-Nota-Abscint-Her2 Demeclocycline Hydrochloride Berubicin Hydrochloride Amb-05X More therapies…

    Learn about Your Condition

    Vulvovaginal pain Ataxia telangiectasia HER2 negative breast cancer Atrophic vulvovaginitis Gingival bleeding Affective disorder Choroidal dystrophy Paraesthesia Fibrosarcoma Testis cancer Conjunctivitis allergic Thymoma Cardiac amyloidosis Meniscus injury Bone sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Diagnostics And Consultation Center Convex Ltd.

Diagnostics And Consultation Center Convex Ltd.

Ulitsa Sinanishko Ezero 11a, Sofia, 1680, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +9

  • A Study Comparing Empasiprubart Versus Intravenous Immunoglobulin in Adults With Chronic Inflammatory Demyelinating Polyneuropathy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Empasiprubart
    • Human Normal Immunoglobulin (Iv)
    Austria Bulgaria Czechia Denmark Estonia France +13

  • A study of navenibart for long-term safety in patients with hereditary angioedema

    Recruiting

    3 1
    Investigated Drugs:
    • NAVENIBART
    Austria Bulgaria Czechia France Germany Hungary +5

  • A study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy

    Recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +9

  • A study testing duvakitug for patients with moderately to severely active ulcerative colitis

    Recruiting

    3 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Duvakitug
    Austria Belgium Bulgaria Czechia France Germany +9

  • Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

    Recruiting

    3 1
    Investigated Drugs:
    • ZILEBESIRAN
    Austria Belgium Bulgaria Czechia Denmark France +11

  • A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

    Recruiting

    3 1
    Investigated Drugs:
    • ADX-324
    Austria Belgium Bulgaria Croatia Czechia France +5

  • A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

    Recruiting

    2 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • IMEROPRUBART
    Austria Belgium Bulgaria Denmark Estonia Finland +13

  • Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

    Recruiting

    3 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Bi 1291583
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ferric Derisomaltose
    Bulgaria Croatia Czechia Denmark Hungary Latvia +6
Previous Page
1 2 3 4 … 10
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!